Showing results (1431-1440 of 7,557) with videos related to

Sort By:
Pageof 756
Molecular Pharmaceutics|September 28, 2012
Chemically self-assembled antibody nanostructures as potential drug carriersAdrian Fegan, Sidath C Kumarapperuma, Carston R Wagner
Molecular Pharmaceutics|October 2, 2012
Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-GLYCOprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridarSelvi Durmus, Rolf W Sparidans, Els Wagenaar, et al.
Molecular Pharmaceutics|September 18, 2012
Gemcitabine versus Modified Gemcitabine: a review of several promising chemical modificationsElodie Moysan, Guillaume Bastiat, Jean-Pierre Benoit
Molecular Pharmaceutics|October 5, 2012
A novel local recycling mechanism that enhances enteric bioavailability of flavonoids and prolongs their residence time in the gutBijun Xia, Qiong Zhou, Zhijie Zheng, et al.
Molecular Pharmaceutics|September 25, 2012
P-glycoprotein, breast cancer resistance protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during blood-brain barrier maturation: involvement of Wnt/β-catenin and endothelin-1 signalingRania Harati, Henri Benech, Anne Sophie Villégier, et al.
Molecular Pharmaceutics|September 4, 2012
Molecular fingerprint-based artificial neural networks QSAR for ligand biological activity predictionsKyaw-Zeyar Myint, Lirong Wang, Qin Tong, et al.
Molecular Pharmaceutics|September 6, 2012
In vitro optimization of EtNBS-PDT against hypoxic tumor environments with a tiered, high-content, 3D model optical screening platformOliver J Klein, Brijesh Bhayana, Yong Jin Park, et al.
Molecular Pharmaceutics|June 20, 2012
High gene transfer by the osmotic polysorbitol-mediated transporter through the selective caveolae endocytic pathwayQuynh-Phuong Luu, Ji-Young Shin, You-Kyoung Kim, et al.
Molecular Pharmaceutics|June 22, 2012
Exploring the mechanism of plasmid DNA nuclear internalization with polymer-based vehiclesGiovanna Grandinetti, Theresa M Reineke
Molecular Pharmaceutics|July 26, 2012
Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeuticThommey P Thomas, Baohua Huang, Seok Ki Choi, et al.
Pageof 756